Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia (Q37144977)
Jump to navigation
Jump to search
scientific article published on January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia |
scientific article published on January 2008 |
Statements
1 reference
Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia (English)
1 reference
Kevin J Anstrom
1 reference
Shelby D Reed
1 reference
Yanhong Li
1 reference
Kevin A Schulman
1 reference
1 January 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference